Second-line treatment with dasatinib in patients resistant to imatinib can select novel inhibitor-specific BCR-ABL mutants in Ph+ ALL
| Image |  |
|---|---|
| Description | article by Simona Soverini et al published March 2007 in Lancet Oncology Commission |
| Author/s |
author: Gianantonio Rosti Michele Baccarani Michela Rondoni Fausto Castagnetti Giovanni Martinelli Simona Soverini Alessandra Gnani Sabrina Colarossi Stefania Paolini |
| Publication date | March 2007 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |